Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 12, 2021 09:15 ET | Source: BioSig Technologies, Inc.

BioSig’s PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias

Westport, CT, Oct. 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
October 04, 2021 08:30 ET | Source: BioSig Technologies, Inc.

Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiovascular Electrophysiology

Westport, CT, Oct. 04, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal...
September 28, 2021 09:15 ET | Source: BioSig Technologies, Inc.

BioSig Selects Plexus Corp. as its Manufacturing Partner

Westport, CT, Sept. 28, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
September 21, 2021 10:30 ET | Source: BioSig Technologies, Inc.

BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors

Westport, CT, Sept. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
September 13, 2021 08:00 ET | Source: BioSig Technologies, Inc.

BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System

Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
August 31, 2021 10:00 ET | Source: BioSig Technologies, Inc.

BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium

Westport, CT, Aug. 31, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
August 19, 2021 11:00 ET | Source: BioSig Technologies, Inc.

BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium

Westport, CT, Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
July 20, 2021 14:00 ET | Source: BioSig Technologies, Inc.

BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention

Westport, CT, July 20, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
July 13, 2021 14:30 ET | Source: BioSig Technologies, Inc.

BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology

Westport, CT, July 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
July 12, 2021 10:30 ET | Source: BioSig Technologies, Inc.

BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care

Westport, CT, July 12, 2021 (GLOBE NEWSWIRE) -- Company to present results from PURE EP 2.0 Study - a multi-center, blinded, and randomized clinical trialLeading physicians evaluated signal data...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right